Search research articles
Contact Us
Filters
Showing results (21-30 of 147) with videos related to
Page
of 15
Sort By:
The American Journal of Case Reports
|
February 23, 2017
Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
Robert J Allen, Marios Koutsakos, Aeron C Hurt, et al.
Antiviral Research
|
July 7, 2010
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model
Aeron C Hurt, Sue Lowther, Deborah Middleton, et al.
Antiviral Research
|
September 18, 2007
Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues
Hui-Ting Ho, Aeron C Hurt, Jenny Mosse, et al.
Emerging Infectious Diseases
|
March 31, 2010
Influenza virus transmission from horses to dogs, Australia
Peter D Kirkland, Deborah S Finlaison, Ellie Crispe, et al.
Antiviral Research
|
February 17, 2019
Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018
Paulina Koszalka, Danielle Tilmanis, Merryn Roe, et al.
Virus Research
|
May 28, 2004
A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses
Aeron C Hurt, Ian G Barr, Naomi Komadina, et al.
Antiviral Research
|
November 7, 2020
Burden of influenza B virus infection and considerations for clinical management
Hassan Zaraket, Aeron C Hurt, Barry Clinch, et al.
Mbio
|
August 8, 2022
Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
Paulina Koszalka, Ankita George, Vijaykrishna Dhanasekaran, et al.
Influenza and Other Respiratory Viruses
|
February 12, 2020
A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
Paulina Koszalka, Rubaiyea Farrukee, Edin Mifsud, et al.
Influenza and Other Respiratory Viruses
|
November 18, 2014
Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management
Aeron C Hurt, David S Hui, Alan Hay, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 147) with videos related to
Sort By:
Page
of 15
The American Journal of Case Reports
|
February 23, 2017
Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
Robert J Allen, Marios Koutsakos, Aeron C Hurt, et al.
Antiviral Research
|
July 7, 2010
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model
Aeron C Hurt, Sue Lowther, Deborah Middleton, et al.
Antiviral Research
|
September 18, 2007
Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues
Hui-Ting Ho, Aeron C Hurt, Jenny Mosse, et al.
Emerging Infectious Diseases
|
March 31, 2010
Influenza virus transmission from horses to dogs, Australia
Peter D Kirkland, Deborah S Finlaison, Ellie Crispe, et al.
Antiviral Research
|
February 17, 2019
Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018
Paulina Koszalka, Danielle Tilmanis, Merryn Roe, et al.
Virus Research
|
May 28, 2004
A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses
Aeron C Hurt, Ian G Barr, Naomi Komadina, et al.
Antiviral Research
|
November 7, 2020
Burden of influenza B virus infection and considerations for clinical management
Hassan Zaraket, Aeron C Hurt, Barry Clinch, et al.
Mbio
|
August 8, 2022
Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
Paulina Koszalka, Ankita George, Vijaykrishna Dhanasekaran, et al.
Influenza and Other Respiratory Viruses
|
February 12, 2020
A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
Paulina Koszalka, Rubaiyea Farrukee, Edin Mifsud, et al.
Influenza and Other Respiratory Viruses
|
November 18, 2014
Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management
Aeron C Hurt, David S Hui, Alan Hay, et al.
Page
of 15